Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 504061, 11 pages
http://dx.doi.org/10.1155/2015/504061
Research Article

Salutary Effects of Cepharanthine against Skeletal Muscle and Kidney Injuries following Limb Ischemia/Reperfusion

1Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11042, Taiwan
2Department of Anesthesiology, Taipei Tzu Chi Hospital, New Taipei City 23142, Taiwan
3School of Medicine, Tzu Chi University, Hualien 97004, Taiwan
4Department of Pathology, Taipei Tzu Chi Hospital, New Taipei City 23142, Taiwan

Received 18 June 2015; Revised 21 September 2015; Accepted 7 October 2015

Academic Editor: Kuzhuvelil B. Harikumar

Copyright © 2015 Ming-Chang Kao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. B. J. Groeneveld, P. G. H. Raijmakers, J. A. Rauwerda, and C. E. Hack, “The inflammatory response to vascular surgery-associated ischaemia and reperfusion in man: effect on postoperative pulmonary function,” European Journal of Vascular and Endovascular Surgery, vol. 14, no. 5, pp. 351–359, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. I. S. Paterson, J. M. Klausner, R. Pugath et al., “Noncardiogenic pulmonary edema after abdominal aortic aneurysm surgery,” Annals of Surgery, vol. 209, no. 2, pp. 231–236, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Volanska, P. Zavacky, and J. Bober, “Ischaemic-reperfusion damage of tissue and critical limb ischaemia,” Bratislavské Lekárske Listy, vol. 107, no. 6-7, pp. 264–268, 2006. View at Google Scholar · View at Scopus
  4. J. L. Eliason and T. W. Wakefield, “Metabolic consequences of acute limb ischemia and their clinical implications,” Seminars in Vascular Surgery, vol. 22, no. 1, pp. 29–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Szijártó, Z. Turóczi, J. Szabó et al., “Rapidly progressing fatal reperfusion syndrome caused by acute critical ischemia of the lower limb,” Cardiovascular Pathology, vol. 22, no. 6, pp. 493–500, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. I. Yassin, D. W. Harkin, A. A. B. Barros D'Sa, M. I. Halliday, and B. J. Rowlands, “Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction,” World Journal of Surgery, vol. 26, no. 1, pp. 115–121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. F. W. Blaisdell, “The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review,” Cardiovascular Surgery, vol. 10, no. 6, pp. 620–630, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Goksin, F. Adali, Y. Enli et al., “The effect of phlebotomy and mannitol on acute renal injury induced by ischemia/reperfusion of lower limbs in rats,” Annals of Vascular Surgery, vol. 25, no. 8, pp. 1118–1128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Garbaisz, Z. Turoczi, P. Aranyi et al., “Attenuation of skeletal muscle and renal injury to the lower limb following ischemia-reperfusion using mPTP inhibitor NIM-811,” PLoS ONE, vol. 9, no. 6, Article ID e101067, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. A. M. Neto, S. S. D. S. Júnior, V. L. Capelozzi et al., “Effects of cilostazol in kidney and skeletal striated muscle of Wistar rats submitted to acute ischemia and reperfusion of hind limbs,” Acta Cirurgica Brasileira, vol. 27, no. 11, pp. 783–788, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Takhtfooladi, H. A. Takhtfooladi, F. Moayer, P. Karimi, and H. A. Asl, “Effect of Otostegia persica extraction on renal injury induced by hindlimb ischemia-reperfusion: a rat model,” International Journal of Surgery, vol. 13, pp. 124–130, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Adiseshiah, J. M. Round, and D. A. Jones, “Reperfusion injury in skeletal muscle: a prospective study in patients with acute limb ischaemia and claudicants treated by revascularization,” British Journal of Surgery, vol. 79, no. 10, pp. 1026–1029, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Rogosnitzky and R. Danks, “Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions,” Pharmacological Reports, vol. 63, no. 2, pp. 337–347, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Furusawa and J. Wu, “The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: implications for cancer, shock, and inflammatory diseases,” Life Sciences, vol. 80, no. 12, pp. 1073–1079, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Kudo, S. Hagiwara, A. Hasegawa, J. Kusaka, H. Koga, and T. Noguchi, “Cepharanthine exerts anti-inflammatory effects via NF-κB inhibition in a LPS-induced rat model of systemic inflammation,” Journal of Surgical Research, vol. 171, no. 1, pp. 199–204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Huang, G. Hu, C. Wang, H. Xu, X. Chen, and A. Qian, “Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models,” Inflammation, vol. 37, no. 1, pp. 235–246, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Murakami, R. A. Cox, H. K. Hawkins et al., “Cepharanthin, an alkaloid from Stephania cepharantha, inhibits increased pulmonary vascular permeability in an ovine model of sepsis,” Shock, vol. 20, no. 1, pp. 46–51, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Ershun, F. Yunhe, W. Zhengkai, C. Yongguo, Z. Naisheng, and Y. Zhengtao, “Cepharanthine attenuates lipopolysaccharide-induced mice mastitis by suppressing the NF-κB signaling pathway,” Inflammation, vol. 37, no. 2, pp. 331–337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Kusaka, S. Hagiwara, A. Hasegawa, K. Kudo, H. Koga, and T. Noguchi, “Cepharanthine improves renal ischemia-reperfusion injury in rats,” Journal of Surgical Research, vol. 171, no. 1, pp. 212–217, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M.-C. Kao, W.-C. Jan, P.-S. Tsai, T.-Y. Wang, and C.-J. Huang, “Magnesium sulfate mitigates lung injury induced by bilateral lower limb ischemia-reperfusion in rats,” Journal of Surgical Research, vol. 171, no. 1, pp. e97–e106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Duehrkop and R. Rieben, “Refinement of tourniquet-induced peripheral ischemia/reperfusion injury in rats: comparison of 2 h vs 24 h reperfusion,” Laboratory Animals, vol. 48, no. 2, pp. 143–154, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. V. N. Suchkova, R. B. Baggs, and C. W. Francis, “Effect of 40-kHz ultrasound on acute thrombotic ischemia in a rabbit femoral artery thrombosis model: enhancement of thrombolysis and improvement in capillary muscle perfusion,” Circulation, vol. 101, no. 19, pp. 2296–2301, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Guzman, A. E. Rosado, and J. A. Kruse, “Dopamine-1 receptor stimulation impairs intestinal oxygen utilization during critical hypoperfusion,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 284, no. 2, pp. H668–H675, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Duehrkop, J. Denoyelle, S. Shaw, and R. Rieben, “Use of dextran sulfate in tourniquet-induced skeletal muscle reperfusion injury,” Journal of Surgical Research, vol. 187, no. 1, pp. 150–161, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Tan, G. Wang, Y. Guo, D. Gui, and N. Wang, “Preventive effects of a natural anti-inflammatory agent, astragaloside IV, on ischemic acute kidney injury in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 284025, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. M. C. McCormack, E. Kwon, K. R. Eberlin et al., “Development of reproducible histologic injury severity scores: skeletal muscle reperfusion injury,” Surgery, vol. 143, no. 1, pp. 126–133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. H. A. Takhtfooladi, M. A. Takhtfooladi, P. Karimi, H. A. Asl, and S. Z. M. N. Mobarakeh, “Influence of tramadol on ischemia-reperfusion injury of rats' skeletal muscle,” International Journal of Surgery, vol. 12, no. 9, pp. 963–968, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Mishra, K. Mori, Q. Ma et al., “Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin,” Journal of the American Society of Nephrology, vol. 15, no. 12, pp. 3073–3082, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. W. K. Han, V. Bailly, R. Abichandani, R. Thadhani, and J. V. Bonventre, “Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury,” Kidney International, vol. 62, no. 1, pp. 237–244, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. P. M. Honore, R. Jacobs, O. Joannes-Boyau et al., “Biomarkers for early diagnosis of AKI in the ICU: ready for prime time use at the bedside?” Annals of Intensive Care, vol. 2, no. 1, pp. 1–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Huang, W. Wang, C. Tu, Z. Yang, D. Bramwell, and X. Sun, “Hydrogen-rich saline attenuates ischemia-reperfusion injury in skeletal muscle,” Journal of Surgical Research, vol. 194, no. 2, pp. 471–480, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. R. A. Mangiafico and M. Mangiafico, “Medical treatment of critical limb ischemia: current state and future directions,” Current Vascular Pharmacology, vol. 9, no. 6, pp. 658–676, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Mo, R. Zhao, J. Vallejo et al., “Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation,” Cell Cycle, vol. 14, no. 10, pp. 1507–1516, 2015. View at Publisher · View at Google Scholar
  34. A. Gulati, I. Botnaru, and L. A. Garcia, “Critical limb ischemia and its treatments: a review,” The Journal of Cardiovascular Surgery, vol. 56, no. 5, pp. 775–785, 2015. View at Google Scholar
  35. J.-H. Lee, “A new rat pain model of thrombus-induced ischemia,” Methods in Molecular Biology, vol. 851, pp. 213–222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Prisk and J. Huard, “Muscle injuries and repair: the role of prostaglandins and inflammation,” Histology and Histopathology, vol. 18, no. 4, pp. 1243–1256, 2003. View at Google Scholar · View at Scopus
  37. P. Kalinski, “Regulation of immune responses by prostaglandin E2,” Journal of Immunology, vol. 188, no. 1, pp. 21–28, 2012. View at Publisher · View at Google Scholar · View at Scopus